Transarterial radioembolization with Yttrium-90: current status and future prospects.
作者信息
Yang Hua-Yu, Jin Bao, Xu Gang, Sun Le-Jia, Du Shun-Da, Mao Yi-Lei
机构信息
Department of Liver Surgery, Peking Union Medical College (PUMC) Hospital, PUMC & Chinese Academy of Medical Sciences (CAMS), Beijing, P. R. China.
出版信息
Gastroenterol Rep (Oxf). 2020 Jan 27;8(2):164-165. doi: 10.1093/gastro/goz074. eCollection 2020 Apr.
Abstract
摘要
相似文献
1
Transarterial radioembolization with Yttrium-90: current status and future prospects.钇-90经动脉放射性栓塞：现状与未来展望。
Gastroenterol Rep (Oxf). 2020 Jan 27;8(2):164-165. doi: 10.1093/gastro/goz074. eCollection 2020 Apr.
2
Early treatment response evaluation after yttrium-90 radioembolization of liver malignancy with CT perfusion.利用CT灌注评估肝脏恶性肿瘤钇-90放射性栓塞后的早期治疗反应
J Vasc Interv Radiol. 2014 May;25(5):747-59. doi: 10.1016/j.jvir.2014.01.025. Epub 2014 Mar 13.
3
Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma.钇-90经动脉放射性栓塞治疗肝细胞癌
Adv Ther. 2016 May;33(5):699-714. doi: 10.1007/s12325-016-0324-7. Epub 2016 Apr 2.
4
Transarterial Chemoembolization vs Yttrium-90 Transarterial Radioembolization.经动脉化疗栓塞术与钇-90经动脉放射性栓塞术的比较
Gastroenterology. 2017 May;152(6):1623-1624. doi: 10.1053/j.gastro.2017.01.062. Epub 2017 Apr 3.
5
Yttrium-90 microsphere radioembolization for hepatocellular carcinoma.钇-90微球放射性栓塞治疗肝细胞癌
Liver Cancer. 2015 Mar;4(1):16-25. doi: 10.1159/000343878.
6
Yttrium-90 Radioembolization of Hepatocellular Carcinoma-Performance, Technical Advances, and Future Concepts.肝细胞癌的钇-90放射性栓塞——性能、技术进展及未来概念
Semin Intervent Radiol. 2015 Dec;32(4):388-97. doi: 10.1055/s-0035-1564704.
7
Yttrium-90 hepatic radioembolization: clinical review and current techniques in interventional radiology and personalized dosimetry.钇-90肝动脉放射性栓塞：介入放射学临床综述及当前技术与个体化剂量测定
Br J Radiol. 2016 Jun;89(1062):20150943. doi: 10.1259/bjr.20150943. Epub 2016 Mar 24.
8
Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus Y-radioembolization for hepatocellular carcinoma.荟萃分析：药物洗脱微球经动脉化疗栓塞术与钇90放射性栓塞术治疗肝细胞癌的调整间接比较
Eur Radiol. 2017 May;27(5):2031-2041. doi: 10.1007/s00330-016-4548-3. Epub 2016 Aug 25.
9
Assessment of Treatment Response Following Yttrium-90 Transarterial Radioembolization of Liver Malignancies.钇-90经动脉放射性栓塞治疗肝脏恶性肿瘤后治疗反应的评估
Cureus. 2018 Jun 29;10(6):e2895. doi: 10.7759/cureus.2895.
10
Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study.经动脉放射性栓塞联合化疗栓塞治疗双叶肝细胞癌的安全性和有效性：一项单中心回顾性研究
Cardiovasc Intervent Radiol. 2018 Mar;41(3):459-465. doi: 10.1007/s00270-017-1826-7. Epub 2017 Oct 24.
引用本文的文献
1
Yttrium-90 radioembolization treatment strategies for management of hepatocellular carcinoma.钇-90放射性栓塞治疗肝细胞癌的策略
World J Radiol. 2024 Oct 28;16(10):512-527. doi: 10.4329/wjr.v16.i10.512.
2
Practical Considerations When Choosing Chemoembolization versus Radioembolization for Hepatocellular Carcinoma.为肝细胞癌选择化疗栓塞与放射性栓塞时的实际考量
Semin Intervent Radiol. 2024 Mar 14;41(1):48-55. doi: 10.1055/s-0044-1779714. eCollection 2024 Feb.
3
Improved Survival after Transarterial Radioembolisation for Hepatocellular Carcinoma Gives the Procedure Added Value.经动脉放射性栓塞治疗肝细胞癌后生存率的提高赋予了该治疗方法更高的价值。
J Clin Med. 2022 Dec 16;11(24):7469. doi: 10.3390/jcm11247469.
4
Evolutions of the Management of Colorectal Cancer Liver Metastasis: A Bibliometric Analysis.结直肠癌肝转移管理的演变：一项文献计量分析
J Cancer. 2021 Apr 30;12(12):3660-3670. doi: 10.7150/jca.52842. eCollection 2021.
本文引用的文献
1
Y90 Clinical Data Update: Cholangiocarcinoma, Neuroendocrine Tumor, Melanoma, and Breast Cancer Metastatic Disease.Y90临床数据更新：胆管癌、神经内分泌肿瘤、黑色素瘤及乳腺癌转移性疾病
Tech Vasc Interv Radiol. 2019 Jun;22(2):81-86. doi: 10.1053/j.tvir.2019.02.008. Epub 2019 Feb 28.
2
The SIRveNIB and SARAH trials, radioembolization . sorafenib in advanced HCC patients: reasons for a failure, and perspectives for the future.SIRveNIB和SARAH试验、放射性栓塞术与索拉非尼治疗晚期肝癌患者：失败原因及未来展望
Hepatobiliary Surg Nutr. 2018 Dec;7(6):487-489. doi: 10.21037/hbsn.2018.10.06.
3
History and Evolution of Yttrium-90 Radioembolization for Hepatocellular Carcinoma.钇-90放射性栓塞治疗肝细胞癌的历史与演变
J Clin Med. 2019 Jan 7;8(1):55. doi: 10.3390/jcm8010055.
4
Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: is it time to reconsider the current treatment guidelines?
Hepatobiliary Surg Nutr. 2018 Aug;7(4):300-301. doi: 10.21037/hbsn.2018.05.02.
5
Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma.免疫激活是钇-90 放射性栓塞治疗肝细胞癌持续临床应答的基础。
Gut. 2019 Feb;68(2):335-346. doi: 10.1136/gutjnl-2017-315485. Epub 2018 Feb 13.
6
Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion.开发一种预后评分，以预测伴有门静脉侵犯的肝细胞癌对钇-90 放射性栓塞治疗的反应。
J Hepatol. 2018 Apr;68(4):724-732. doi: 10.1016/j.jhep.2017.12.026. Epub 2018 Jan 10.
7
Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience.机构决定采用 Y90 作为原发性肝癌的主要治疗方法，依据是 1000 例患者的 15 年经验。
Hepatology. 2018 Oct;68(4):1429-1440. doi: 10.1002/hep.29691. Epub 2018 Jan 29.
8
Prevention and treatment of complications of selective internal radiation therapy: Expert guidance and systematic review.选择性内放射治疗并发症的预防和治疗：专家指导和系统评价。
Hepatology. 2017 Sep;66(3):969-982. doi: 10.1002/hep.29207. Epub 2017 Jul 27.
9
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.与肝动脉化疗栓塞术相比，钇-90放射性栓塞术显著延长了肝细胞癌患者的疾病进展时间。
Gastroenterology. 2016 Dec;151(6):1155-1163.e2. doi: 10.1053/j.gastro.2016.08.029. Epub 2016 Aug 27.
10
Yttrium-90 Radioembolization for Hepatocellular Carcinoma Prior to Liver Transplantation.肝移植前钇-90放射性栓塞治疗肝细胞癌
World J Surg. 2017 Jan;41(1):241-249. doi: 10.1007/s00268-016-3682-z.
Zotero 插件